C P Quinn
Overview
Explore the profile of C P Quinn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
802
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Purkiss J, Friis L, Doward S, Quinn C
Neurotoxicology
. 2001 Oct;
22(4):447-53.
PMID: 11577803
We have described, in undifferentiated SH-SY5Y human neuroblastoma cells, the relative potency of Clostridium botulinum neurotoxin (BoNT) serotypes A-F Sensitivity of stimulated [3H]-noradrenaline ([3H]-NA) release to the toxins had a...
12.
Chaddock J, Purkiss J, Duggan M, Quinn C, Shone C, Foster K
Growth Factors
. 2000 Oct;
18(2):147-55.
PMID: 11019785
Nerve growth factor (NGF) receptor binding, internalisation and transportation of NGF has been identified as a potential route of delivery for other molecules. A derivative of Clostridium botulinum neurotoxin type...
13.
Chaddock J, Purkiss J, Friis L, Broadbridge J, Duggan M, Fooks S, et al.
Infect Immun
. 2000 Apr;
68(5):2587-93.
PMID: 10768948
Clostridial neurotoxins potently and specifically inhibit neurotransmitter release in defined cell types by a mechanism that involves cleavage of specific components of the vesicle docking/fusion complex, the SNARE complex. A...
14.
Bowen J, Quinn C
J Appl Microbiol
. 1999 Sep;
87(2):270-8.
PMID: 10475964
The segregational stability of a small, theta-replicating, non-mobilizable shuttle plasmid (pAEX-5E) was determined in fully virulent (pX01+/pX02+), partially cured (pX01+/pX02- and pX01-/pX02+) and fully cured (pX01-/pX02-) derivatives of Bacillus anthracis...
15.
Purkiss J, Welch M, Doward S, Foster K, Quinn C
Biochem Soc Trans
. 1998 Jul;
26(2):S108.
PMID: 9649783
No abstract available.
16.
Wagner J, Schmidtke D, Quinn C, Fleming T, Bernacky B, Heller A
Proc Natl Acad Sci U S A
. 1998 May;
95(11):6379-82.
PMID: 9600973
The performance of an amperometric biosensor, consisting of a subcutaneously implanted miniature (0.29 mm diameter, 5 x 10(-4) cm2 mass transporting area), 90 s 10-90% rise/decay time glucose electrode, and...
17.
Schmidtke D, Pishko M, Quinn C, Heller A
Anal Chem
. 1996 Sep;
68(17):2845-9.
PMID: 8794921
Low error rates are essential if lives of patients are to depend on readings of implanted sensors, such as glucose sensors in insulin-dependent diabetic patients. To verify the operation and...
18.
Papageorgiou A, Quinn C, Beer D, Brehm R, Tranter H, Bonventre P, et al.
Protein Sci
. 1996 Aug;
5(8):1737-41.
PMID: 8844860
Toxic shock syndrome toxin-1 (TSST-1) is one of a family of staphylococcal exotoxins recognized as microbial superantigens. The toxin plays a dominant role in the genesis of toxic shock in...
19.
Quinn C, Pishko M, Schmidtke D, Ishikawa M, Wagner J, Raskin P, et al.
Am J Physiol
. 1995 Jul;
269(1 Pt 1):E155-61.
PMID: 7631771
The time between intravenous injection of a glucose bolus and the time the glucose concentration peaked in the subcutaneous tissue was measured in pentobarbital-anesthetized rats with implanted 290-microns-diameter amperometric sensors....
20.
Quinn C, Pathak C, Heller A, Hubbell J
Biomaterials
. 1995 Mar;
16(5):389-96.
PMID: 7662824
A copolymer containing 88% 2-hydroxyethyl methacrylate (HEMA), 9% poly(ethylene glycol) (MW 18.5 kDa) tetra-acrylate and 3% ethylene dimethacrylate was prepared and evaluated for use as a biocompatible interface between glucose...